Differential effect of modified capped RNA substrates on influenza virus transcription

Virus Research

Volumn 50, Issue 1, 1997, Pages 65-75

  Cianci, Christopher ^a   Colonno, Richard J ^a   Krystal, Mark ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

Cap binding; Phosphorothioate; RNA polymerase; Short capped oligonucleotide; Transcription inhibitor

Indexed keywords

PHOSPHOROTHIOIC ACID; RNA POLYMERASE;

ARTICLE; CAPPING PHENOMENON; CONTROLLED STUDY; INFLUENZA VIRUS; NONHUMAN; PRIORITY JOURNAL; RNA TRANSCRIPTION; VIRUS TRANSCRIPTION;

INFLUENZA VIRUS;

EID: 0030785703     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(97)00063-4     Document Type: Article

References (40)

1. Blaas D., Patzelt E., Kuechler E. Identification of the cap binding protein of influenza virus. Nucleic Acids Res. 10:1982;4803-4812.
2. Blaas D., Patzelt E., Kuechler E. Cap recognizing protein of influenza virus. Virology. 116:1982;339-348.
3. Braam J., Ulmanen I., Krug R.M. Molecular model of a eukaryotic transcription complex: Functions and movements of influenza P proteins during capped RNA-primed transcription. Cell. 34:1983;609-618.
4. Bouloy M., Plotch S.J., Krug R.M. Both the 7-methyl and the 2′-O-methyl groups in the cap of mRNA strongly influence its ability to act as primer for influenza virus RNA transcription. Proc. Natl. Acad. Sci. USA. 77:1980;3952-3956.
5. Chowrira B.M., Burke J.M. Extensive phosphorothioate substitution yields highly active and nuclease-resistant hairpin ribozymes. Nucleic Acids Res. 20:1992;2835-2840.
6. Chung T.D.Y., Cianci C., Hagen M., Terry B.T., Matthews J.T., Krystal M., Colonno R.J. Biochemical studies on capped RNA primers identify a class of oligonucleotide inhibitors of the influenza virus RNA polymerase. Proc. Natl. Acad. Sci., USA. 91:1994;2372-2376.
7. Cianci C., Chung T.D.Y., Meanwell N., Putz H., Hagen M., Colonno R.J., Krystal M. Identification of N-Hydroxamic acid and N-hydroxy-imide compounds that inhibit the capped RNA-dependent transcriptase of influenza virus. Antiviral Agents Chemother. 7:1996;353-360.
8. Cianci C., Tiley L., Krystal M. Differential activation of the influenza virus polymerase via template RNA binding. J. Virol. 69:1995;3995-3999.
9. Galarza J.M., Peng Q., Shi L., Summers D.F. Influenza A virus RNA-dependent RNA polymerase: analysis of RNA synthesis in vitro. J. Virol. 70:1996;2360-2368.
10. 2 and PA subunits: a model for the viral RNA polymerase structure. Nucleic Acids Res. 24:1996;4456-4463.
11. Hagen M., Chung T.D.Y., Butcher J.A., Krystal M. Recombinant influenza virus polymerase: requirement of both 5′ and 3′ viral ends for endonuclease activity. J. Virol. 68:1994;1509-1515.
12. Hagen M., Tiley L., Chung T.D.Y., Krystal M. The role of template-primer interactions in cleavage and initiation by the influenza virus polymerase. J. Gen. Virol. 76:1995;603-611.
13. Hensens O.D., Goetz M.A., Liesch J.M., Zink D.L., Raghoobar S.L., Helms G.L., Singh S.B. Isolation and structure of flutimide, a novel endonuclease inhibitor of influenza virus. Tetrahedron Lett. 36:1995;2005-2008.
14. Honda A., Mizumoto K., Ishihama A. RNA polymerase of influenza virus. Dinucleotide-primed initiation of transcription at specific positions on viral RNA. Proc. Natl. Acad. Sci. USA. 83:1986;5987-5991.
15. Honda A., Mukaigawa J., Yokoiyama A., Kato A., Ueda S., Nagata K., Krystal M., Nayak D.P., Ishihama A. Purification and molecular structure of RNA polymerase from influenza virus A/PR8. J. Biochem. 107:1990;624-628.
16. Hsu M.-T., Parvin J.D., Gupta S., Krystal M., Palese P. Genomic RNAs of influenza viruses are held in a circular conformation in virions and in infected cells by a terminal panhandle. Proc. Natl. Acad. Sci. USA. 84:1987;8140-8144.
17. 7GpppNm). J. Biochem. 97:1985;655-661.
18. Kawasaki A.M., Casper M.D., Freier S.M., Lesnik E.A., Zounes M.C., Cummins L.L., Gonzalez C., Cook P.D. Uniformly modified 2′-deoxy-2′-fluoro phosphorothioate oligonucleotides as nuclease-resistant antisense compounds with high affinity and specificity for RNA targets. J. Med. Chem. 36:1993;831-841.
19. Krug R.M. Priming of influenza viral RNA transcription by capped heterologous RNAs. Curr. Top. Microbiol. Immunol. 93:1981;125-150.
20. Krug, R.M., Alonso-Caplen, F.V., Julkunen, I., Katze, M.G., 1989. Expression and replication of the influenza virus genome. In: Krug, R.M. (Ed.), The Influenza Viruses. Plenum Press, New York, pp. 89-152.
21. Krug R.M., Broni B.A., LaFiandra A.J., Morgan M.A., Shatkin A.J. Priming and inhibitory activities of RNAs for the influenza viral transcriptase do not require base pairing with the virion template RNA. Proc. Natl. Acad. Sci. USA. 77:1980;5874-5878.
22. Lamb R.A., Choppin P.W. The gene structure and replication of influenza virus. Annu. Rev. Biochem. 52:1983;467-506.
23. Martin S.A., Moss B. Modification of RNA by mRNA guanylyltransferase and mRNA(guanine-7-)methyltransferase from vaccinia virions. J. Biol. Chem. 250:1975;9330-9335.
24. Olsen D.B., Benseler F., Cole J.L., Stahlhut M.W., Dempski R.E., Darke P.L., Kuo L.C. Elucidation of basic mechanistic and kinetic properties of influenza endonuclease using chemically synthesized RNAs. J. Biol. Chem. 271:1996;7435-7439.
25. Penn C.R., Mahy B.W.J. Capped mRNAs may stimulate the influenza virion polymerase by allosteric modulation. Virus Res. 1:1984;1-13.
26. 7GpppXm)-dependent influenza virion endonuclease cleaves capped RNA's to generate the primers that initiate viral RNA transcription. Cell. 23:1981;847-858.
27. Robertson H.D., Dickson E., Plotch S.J., Krug R.M. Identification of the RNA region transferred from a representative primer, Beta-globin mRNA, to influenza mRNA during in vitro transcription. Nucleic Acids Res. 8:1980;925-942.
28. Rochavansky O.M. RNA synthesized by ribonucleoprotein polymerase complexes isolated from influenza virus. Virology. 73:1976;327-338.
29. Scholtissek C. The genome of the influenza virus. Curr. Top. Microbiol. Immunol. 80:1978;139-169.
30. Shapiro G.I., Krug R.M. Influenza virus RNA replication in vitro: synthesis of viral template RNAs and virion RNAs in the absence of an added primer. J. Virol. 62:1988;2285-2290.
31. Shatkin A.J. Capping of eucaryotic mRNAs. Cell. 9:1976;645-653.
32. Shaw M.W., Lamb R.A. A specific sub-set of host-cell mRNAs prime influenza virus mRNA synthesis. Virus Res. 1:1984;455-467.
33. 2 subunit of the influenza A virus RNA polymerase binds cap groups as an isolated subunit. Virus Res. 42:1996;1-9.
34. Shimayama T., Nishikawa F., Nishikawa S., Taira K. Nuclease-resistant chimeric ribozymes containing deoxyribonucleotides and phosphorothioate linkages. Nucleic Acids Res. 21:1993;2605-2611.
35. Smith J.C., Raper R.H., Bell L.D., Stebbing N., McGeoch D. Inhibition of influenza virion transcriptases by polynucleotides. Virology. 103:1980;245-249.
36. Tiley L., Hagen M., Matthews J.T., Krystal M. Sequence-specific binding of the influenza virus RNA polymerase to sequences located at the 5′ ends of the viral RNAs. J. Virol. 68:1994;5108-5116.
37. Tomassini J.E., Davies M.E., Hastings J.C., Lingham R., Mojena M., Raghoobar S.L., Singh S.B., Tkacz J.S., Goetz M.A. A novel antiviral agent which inhibits the endonuclease of influenza viruses. Antimicrob. Agents Chemother. 40:1996;1189-1193.
38. Tomassini J., Selnick H., Davies M.E., Armstrong M.E., Baldwin J., Bourgeois M., Hastings J., Hazuda D., Lewis J., McClements W., Ponticello G., Radzilowski E., Smith G., Tebben A., Wolfe A. Inhibition of cap (m7GpppXm)-dependent endonuclease of influenza virus by 4-substituted 2,4-dioxobutanoic acid compounds. Antimicrob. Agents Chemother. 38:1994;2827-2837.
39. Toyoda T., Adyshev D.M., Kobayashi M., Iwata A., Ishihama A. Molecular assembly of the influenza virus RNA polymerase:determination of the subunit-subunit contact sites. J. Gen. Virol. 77:1996;2149-2157.
40. Ulmanen I., Broni B.A., Krug R.M. Role of two of the influenza virus core P proteins in recognizing Cap-1 structures (m7GpppNm) on RNAs and in initiating viral RNA transcription. Proc. Natl. Acad. Sci. USA. 78:1981;7355-7359.